Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rhianne Voogd"'
Autor:
Chiara M, Cattaneo, Thomas, Battaglia, Jos, Urbanus, Ziva, Moravec, Rhianne, Voogd, Rosa, de Groot, Koen J, Hartemink, John B A G, Haanen, Emile E, Voest, Ton N, Schumacher, Wouter, Scheper
Publikováno v:
Nature biotechnology.
Cancer neoantigens that arise from tumor mutations are drivers of tumor-specific T cell responses, but identification of T cell-recognized neoantigens in individual patients is challenging. Previous methods have restricted antigen discovery to select
Autor:
Xin Lei, Paul Geraeds Kemps, Tom de Wit, Jelske Borst, Yanling Xiao, Jannie Borst, Rhianne Voogd, Joanna Grabowska, Eline C. Steenwijk, Astrid G. S. van Halteren, Cor van den Bos, Jennifer Picarsic
Publikováno v:
Blood, 136(19), 2188-2199. American Society of Hematology
Blood, 136(19), 2188-2199. AMER SOC HEMATOLOGY
Xiao, Y, van Halteren, A G S, Lei, X, Borst, J, Steenwijk, E, de Wit, T, Grabowska, J, Voogd, R, Kemps, P, Picarsic, J, van den Bos, C & Borst, J 2020, ' Bone marrow-derived myeloid progenitors as driver mutation carriers in high-and low-risk Langerhans cell histiocytosis ', Blood, vol. 136, no. 19, pp. 2188-2199 . https://doi.org/10.1182/blood.2020005209
Blood, 136(19), 2188-2199. AMER SOC HEMATOLOGY
Xiao, Y, van Halteren, A G S, Lei, X, Borst, J, Steenwijk, E, de Wit, T, Grabowska, J, Voogd, R, Kemps, P, Picarsic, J, van den Bos, C & Borst, J 2020, ' Bone marrow-derived myeloid progenitors as driver mutation carriers in high-and low-risk Langerhans cell histiocytosis ', Blood, vol. 136, no. 19, pp. 2188-2199 . https://doi.org/10.1182/blood.2020005209
Langerhans cell histiocytosis (LCH) is a myeloid neoplasia, driven by sporadic activating mutations in the MAPK pathway. The misguided myeloid dendritic cell (DC) model proposes that high-risk, multisystem, risk-organ–positive (MS-RO+) LCH results